Stay updated on Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check7 days agoChange DetectedThe site’s displayed revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, and the older revision v3.6.6 was removed from the list, reflecting updates to the record's version history.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry (v3.6.6) was added to the Study Record Versions, updating the revision history to reflect the latest state of the record. The previous revision (v3.6.5) was removed from the list.SummaryDifference0.1%

- Check70 days agoChange DetectedA newer revision (v3.6.5) was added to the study's history, and the previous revision (v3.6.4) was removed from the visible history. This updates the history view to reflect the latest revision of the record.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision entry labeled v3.6.4 was added to the Study Record history, and the previous entry v3.6.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.